Liquid biopsies have gained an increasing interest in the last years among medical and
scientific communities. Indeed, the value of liquid effusions, while less invasive and more …

Simple Summary Mesothelioma is a deadly disease with a dismal prognosis. Since its
discovery, mesothelin, a cell surface protein, has been a promising biomarker and …

The early-stage diagnosis and monitoring of disease evolution is still one of the most
challenging tasks in the field of cancer research. Several research have been driven toward …

Malignant pleural mesothelioma (MPM) is an aggressive tumor with poor prognosis and
limited therapeutic options. The extracellular matrix protein fibulin-3/EFEMP1 accumulates in …

Objectives Malignant pleural mesothelioma (MPM) is an aggressive malignancy with dismal
prognosis but variable course of disease. To support diagnosis and to risk stratify patients …

Malignant pleural mesothelioma (MPM) is a type of cancer originating from the pleura with
high aggressiveness and poor prognosis. A timely diagnosis is crucial to improve its …

Malignant pleural mesothelioma (MPM) is a cancer associated with asbestos exposure and
its diagnosis is challenging due to the moderate sensitivities of the available methods. In this …

Malignant pleural mesothelioma (MPM) is a rare, aggressive, and devastating disease of the
thoracic cavity associated with asbestos exposure. In recent years, MPM incidence has been …

Malignant mesothelioma (MM) is characterized by poor prognosis and short survival.
Extracellular vesicles (EVs) are membrane-bound particles released from cells into various …

Objectives Soluble mesothelin-related protein (SMRP) and fibulin-3 serum levels may serve
as diagnostic and prognostic biomarkers of malignant pleural mesothelioma (MPM). Here …